covance

LabCorp, Covance launch new effort focusing on gene therapies

Posted by WRAL TechWire | Jan 14, 2020

LabCorp has introduced a suite of cell and gene therapy development services from Covance, its drug development business, to help biopharmaceutical companies develop cell and gene therapies for cancer and other diseases.

LabCorp borrows $850M, closes $485M Envigo deal; job swaps involve hundreds

Posted by WRAL TechWire | Jun 4, 2019

Global life science giant LabCorp has closed on its $485 million deal with Envigo, a research firm, and has borrowed $850 million to help finance it.

LabCorp: Ransomware attack, hurricane cut profits by 10%; stock tumbles 4,4%

Posted by WRAL TechWire | Oct 24, 2018

A ransomware attack in July and Hurricane Florence combined for a double whammy on global life science giant LabCorp’s profits. And its stock is taking a hit as a result.

LabCorp sells its food supply chain group for $670M in cash

Posted by WRAL TechWire | Apr 30, 2018

Global life sciences firm LabCorp is selling its Covance Food Solutions Group to Eurofins Scientific in a deal valued at $670 million in cash.

Meet CEO David King, the practical strategist who’s driving LabCorp’s ‘tremendous run’

Posted by Barry Teater | Feb 28, 2018

In January LabCorp was named to Fortune magazine’s list of the “World’s Most Admired Companies.” Last year it was named to Forbes’ ranking of the “World’s Most Innovative Companies.” The Burlington-based company continues to grow in size and reputation. And driving LabCorp ever higher is David King, its chair and CEO, who talks about the “tremendous run” of the life science giant under his direction.